MSB 2.10% $1.17 mesoblast limited

Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-176

  1. 11,423 Posts.
    lightbulb Created with Sketch. 504
    https://clinicaltrials.gov/ct2/show/NCT04456439

    Article I suspect more about information to industry that trial is on going.
    Last edited by eyeswideopen: 18/02/21
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.